Meet our founder
Preview text: How (and why) we innovate.
No image available for this email.
- Subject
- Meet our founder
- Preview text
- How (and why) we innovate.
- From
- contact@
saltgrooming.com - Brand
- Salt Grooming
- ESP
- Klaviyo
- Sent
- Thu May 21, 2026, 2:44 AM ET
- Size
- 46 KB
- Images
- 12
- Links
- 10, 3 of them buttons
- Subject length
- 16 characters
Against Salt Grooming's usual
Sent in the 2 AM hour, which holds 4% of its emails; 19% arrive in the 5 AM hour. The subject is 16 characters; its average is 28.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Salt Grooming <[email protected]>
- Subject
- Meet our founder
- Date
- Thu, 21 May 2026 06:44:03 +0000 (UTC)
- Message-ID domain
- geopod-ismtpd-16
- Return-Path domain
- contact.saltgrooming.com
- DKIM signature
- d=saltgrooming.com s=kl2
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from o1401.shared.klaviyomail.com [168.245.125.63] by our receiving server with ESMTPS
- by recvd-…-52p79 with SMTP
- from (unnamed) by geopod-ismtpd-16 with HTTP
Other sending headers (names only): X-Kmail-Account, X-Kmail-Flow, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse, X-SG-EID, X-SG-ID, X-Entity-ID
Sent just before and after
| May 27, 2026 2:45 PM | Most men use the wrong shampoo. Do you? | |
| May 22, 2026 6:30 AM | There's a 66% chance you need this. | |
| May 22, 2026 2:43 AM | Your 10% welcome discount is about to expire | |
| May 21, 2026 2:44 AM | Meet our founder (this email) | |
| May 20, 2026 3:43 AM | See Why Everyone Loves Salt Grooming | |
| May 20, 2026 2:43 AM | Don’t just take our word for it… | |
| May 19, 2026 3:43 AM | Haircare excellence awaits you |
More from Salt Grooming
All Salt Grooming emailsNov 5, 2026 2:01 PM
Will you still be using it in February?
Nov 2, 2026 6:00 AM
Oct 31, 2026 6:15 AM
Oct 29, 2026 3:30 PM
Oct 28, 2026 5:30 AM
Oct 25, 2026 3:30 PM
Buying the wrong products is expensive
Oct 22, 2026 2:01 PM
A clinically proven breakthrough
Oct 16, 2026 6:00 AM







